EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Springer Nature AG & Co. KGaA (SPGNY) fair value: what the stock is really worth

As of Sep 25, 2026: fair value of Springer Nature AG & Co. KGaA $35.97, price $11.44, upside +214.4%, quality 73 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Communication Services · US · Home Germany

SN Springer Nature AG & Co. KGaA logo Thin data Sep 24, 2026

Springer Nature AG & Co. KGaA

SPGNY · US

Clearly undervaluedStrong Fair Value upside, but quality is only moderate.

✓Fair value $35.97 · Strongly undervalued (+214.4%)
✓Quality 73/100
✓Healthy Growth (revenue YoY +4.3 %/yr)
✓Solidly profitable · 18.5% net margin (TTM)
✓Moderate debt · generates free cash flow
✓7.3% dividend yield · Well covered
✓Ranks above peers (11/13)
✓Wide moat 75/100
!Evidence only low, so the estimate is less certain
!Weak on future: 28 out of 100
Watch Springer Nature AG & Co. KGaA for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$12.55 $10.17 Fair Value $35.97 May 2026 Sep 2026

White line = price, green steps = our fair value per fiscal year. As of Sep 24, 2026.

How to read this chart

5‑month range $10.17 – $12.55 · fair‑value band $25.29 – $49.91 · the $11.44 price screens below the $35.97 fair value. As of Sep 24, 2026.

Follow Springer Nature AG & Co. KGaA in your weekly email

Every Wednesday you see whether Springer Nature AG & Co. KGaA is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Springer Nature AG & Co. KGaA, together with its subsidiaries, engages in the publishing business in Germany, the United Kingdom, the United States, and internationally. The company operates through three segments: Research, Education, and Health.

Show more

Springer Nature AG & Co. KGaA, together with its subsidiaries, engages in the publishing business in Germany, the United Kingdom, the United States, and internationally. The company operates through three segments: Research, Education, and Health. It offers journals across various academic disciplines under the Nature Portfolio and Springer brand names; books in print and digital formats across various scientific disciplines, including monographs, textbooks, conference proceedings, handbook series, reference works, and briefs under the Springer and Palgrave Macmillan brand names; and support services to researchers, institutions, and industry professionals with AI-powered tools and services, such as AdisInsight, Springer Nature Experiments, protocols.io, and SpringerMaterials, as well as professional development and career services under the Nature Masterclasses, Nature Careers, and Nature Conferences brand names. The company also provides English language teaching content and national curricula learning resources under the Macmillan Education brand name. In addition, it offers specialist information and services to healthcare professionals under the Springer Medizin brand name; publications, learning solutions, and professional services to healthcare practitioners and students under the BSL brand name; content and services related to drug treatments, medical devices, and diagnostics under the Springer Health+ brand name; and Cureus Journal of Medical Science, a peer-reviewed OA medical journal. The company was founded in 1842 and is based in Berlin, Germany. Springer Nature AG & Co. KGaA operates as a subsidiary of GvH Vermögensverwaltungsgesellschaft Xxxiii mbH.

Stock analysis

Springer Nature AG & Co. KGaA (SPGNY) currently trades at $11.44, while our model-based Fair Value estimate is $35.97, implying the stock looks roughly 68.2% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of $38.93 per share, and 21 of the 23 models we run sit above the $11.44 price.

Bear case: the Asset-Based group reads lowest at $7.68, and 2 of the 23 models stay below the price. Evidence for this calculation is low.

Scenario range: $25.29 (bear) to $49.91 (bull), the price of $11.44 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 73/100 (solid quality), in the Communication Services sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Springer Nature AG & Co. KGaA reported revenue of €1.9B in FY2025 versus €1.9B in FY2023, a compound +2.0%/yr. Reported net income was €356M in FY2025, compounding +379.0%/yr from FY2023.

Key figures

Market cap $2.3B · P/E ratio 5.5 · P/S ratio 1.02 · EPS (TTM) $2.07 · Dividend yield 7.3% · Net margin 18.5% · Return on equity 18.5% · Return on assets (EBIT) 8.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 58 out of 100 (medium confidence).

What moves the price

For context, the median of 10 Communication Services peers we cover trades at 0% fair-value upside, at 214%, SPGNY screens cheaper than that median.

Fair Value models

Bear $25.29 Fair Value $35.97 Bull $49.91
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($0.9376 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF $27.54 $40.82 $58.66 73
Growth DCF $28.50 $40.93 $56.97 72
EPV $12.27 $15.25 $17.81 71
All 23 models by family
DCF Models
FCF DCF $27.54 $40.82 $58.66 73
Owner Earnings $31.58 $46.44 $66.39 69
5Y Revenue Exit $19.67 $30.69 $43.96 66
5Y EBITDA Exit $26.44 $42.58 $60.31 68
5Y P/E Exit $24.36 $38.93 $53.16 64
10Y Revenue Exit $21.82 $31.99 $44.01 61
10Y EBITDA Exit $26.56 $39.80 $55.52 62
10Y P/E Exit $25.29 $37.40 $50.49 58
Earnings-Based
Graham-Dodd $13.69 $29.57 $37.60 59
PEG = 1.0 $4.59 $6.56 $8.53 52
EPV $12.27 $15.25 $17.81 71
Multiples
P/E Multiple $33.22 $44.29 $55.37 63
P/S Multiple $25.67 $34.23 $42.78 58
P/B Multiple $25.67 $34.23 $42.78 55
EV/EBIT $24.90 $35.37 $45.85 65
EV/EBITDA $30.54 $42.90 $55.25 67
EV/Revenue $16.36 $26.17 $35.99 53
Asset-Based
NCAV (Graham) $5.73 $7.68 $11.47 54
Growth DCF
Growth DCF $28.50 $40.93 $56.97 72
Rev-Margin DCF $19.67 $31.24 $43.54 66
Economic Profit
Residual Income $12.44 $15.24 $21.16 69
ROIC Compounder $12.38 $16.19 $20.36 66
Growth Earnings
Growth-Adj P/E $24.50 $35.00 $45.49 61

Open the full fair value analysis →

Notify me when SPGNY reaches fair value

Put SPGNY on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 73/100

Of which business quality 67 · Market factors (momentum, volatility) 41

Profitability 55
Margins and returns on capital today
Quality Growth 64
Are margins and returns improving?
Cashflow 91
Earnings quality: real cash, not paper profit
Fin. Strength 33
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 38
Calm price path (market factor)
Momentum 51
Price trend over the last 3–12 months (market factor)
52W Momentum 28
Distance to the 52-week high (market factor)
Net Issuance 80
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 77/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 2 usable fiscal years, at least 4 required
not computed

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−11.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+3.7%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in EUR, euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about −13.8% a year for the price and +1.4% for the forecasts.
Forecast 2026 (sales)+2.5%
Forecast 2027 (sales)+4.4%
Projected 2028 (sales)+4.1%
Projected 2029 (sales)+3.8%
Projected 2030 (sales)+3.5%

Watch SPGNY, get fair value alerts →

Compare Springer Nature AG & Co. KGaA with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Publishing · 102 stocks

Beats the industry median on 11/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 73 · Top 25%
Fair Value upside +57.1% · Above median
Profitability
Return on equity (TTM) 18.5% · Top 25%
Return on assets 5.6% · Top 25%
Net margin (TTM) 18.5% · Top 25%
Operating margin (TTM) 28.3% · Top 25%
Growth and dividend
Revenue growth 5.5% · Top 25%
Dividend yield (TTM) 7.3% · Top 25%
Balance sheet
Debt / equity 0.70× · Highest 25%

Valuation Multiplesvs Publishing median · lower = cheaper

P/E (TTM) 5.5× · Cheapest 25%
P/B 1.00× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (TTM) 1.05× · Pricier than median
P/FCF 3.9× · Cheapest 25%
EV/EBITDA 4.5× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 49
FUTURE (revenue growth)28 · sector 0
PAST (return on equity)74 · sector 25
HEALTH (low debt)65 · sector 99
DIVIDEND (yield)100 · sector 59

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Publishing stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
The New York Times Company NYT $63.70 $42.10 −34%
Xinhua Winshare Publishing and Media Co 601811 ¥21.12 ¥21.02 +0%
Jiangsu Phoenix Publishing & Media Corporation 601928 ¥8.34 ¥9.14 +10%
China South Publishing & Media Group 601098 ¥10.27 ¥10.70 +4%
People.cn CO., LTD 603000 ¥16.51 ¥4.23 −74%
China Science Publishing & Media Ltd 601858 ¥22.11 ¥10.08 −54%
Zhejiang Publishing & Media Co 601921 ¥7.56 ¥7.45 −1%
John Wiley & Sons, Inc WLY $47.76 $61.05 +28%
Shandong Publishing&Media Co 601019 ¥6.84 ¥11.60 +70%
TX Group TXGN CHF 167.40 CHF 43.33 −74%

Explore undervalued stocks

More undervalued Communication Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Springer Nature AG & Co. KGaA · Fair Value
$35.97 +68%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Springer Nature AG & Co. KGaA Fair Value". https://www.fairvalue-calculator.com/stock/SPGNY

Frequently asked questions

Is Springer Nature AG & Co. KGaA (SPGNY) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $35.97 versus the last price from Sep 25, 2026 of $11.44, about +214% upside (undervalued).
What is the fair value of SPGNY?
Our model-based fair value for Springer Nature AG & Co. KGaA is $35.97 (as of Sep 24, 2026), built from audited fundamentals. Last price (from Sep 25, 2026): $11.44.
What is the quality score of SPGNY?
Springer Nature AG & Co. KGaA has a Quality Score of 73/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Springer Nature AG & Co. KGaA (SPGNY)?
Our model-based price target is the fair value of $35.97 (as of Sep 24, 2026) from 23 valuation models. Cautious scenario $25.29, optimistic scenario $49.91. It is a calculation from audited fundamentals, not an analyst target.
What is the Springer Nature AG & Co. KGaA stock forecast for 2026?
Our models put fair value at $35.97, about +214% upside versus the last price from Sep 25, 2026 of $11.44 (undervalued). Cautious scenario $25.29, optimistic scenario $49.91. The calculation is refreshed regularly with new filings.
What is the revenue of Springer Nature AG & Co. KGaA (SPGNY)?
Springer Nature AG & Co. KGaA reported trailing-twelve-month revenue of about €1.9B (latest available figure, as of Sep 24, 2026).
Does Springer Nature AG & Co. KGaA pay a dividend?
Springer Nature AG & Co. KGaA currently shows a dividend yield of about 7.26% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Springer Nature AG & Co. KGaA (SPGNY)?
For today's price to be fair in a discounted-cash-flow model, Springer Nature AG & Co. KGaA would have to grow free cash flow by -11.9 % per year for five years (discount rate 9.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 2 years revenue grew +2.0 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of SPGNY use?
Our models discount Springer Nature AG & Co. KGaA at 9.7 %: a base by market capitalisation (mid), country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Springer Nature AG & Co. KGaA that is -11.9 % per year a year over ten years, using the same discount rate (9.7 %) and the same formula as our fair value.
How much growth has Springer Nature AG & Co. KGaA (SPGNY) delivered so far?
Over the past 2 years revenue at Springer Nature AG & Co. KGaA grew +2.0 % a year. The price currently implies -11.9 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Springer Nature AG & Co. KGaA (SPGNY) growing?
The median revenue growth in the sector is +3.0 % a year. That is the yardstick for the growth priced into Springer Nature AG & Co. KGaA (-11.9 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Springer Nature AG & Co. KGaA (SPGNY)?
The free-cash-flow yield on the price is 25.74 %: that much free cash flow Springer Nature AG & Co. KGaA produces per unit of market value. When it exceeds the discount rate of our models (9.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Springer Nature AG & Co. KGaA (SPGNY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Springer Nature AG & Co. KGaA it is $35.97 per share (as of Sep 24, 2026), against a price of $11.44. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Springer Nature AG & Co. KGaA stock overvalued or undervalued in 2026?
As of Sep 24, 2026, SPGNY trades below its calculated fair value: price $11.44, fair value $35.97, a gap of about +214% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SPGNY?
No. The price is what the market pays today ($11.44); the fair value is what the company's own numbers justify ($35.97). For Springer Nature AG & Co. KGaA the two are $24.53 per share apart. That gap is exactly why we show both numbers side by side.
How much is Springer Nature AG & Co. KGaA worth?
The market values Springer Nature AG & Co. KGaA at about $2.3B (market capitalisation, as of Sep 24, 2026). Per share that is $11.44; our models calculate a fair value of $35.97 per share.
What do the bullish and bearish scenarios say about SPGNY?
Our models span a range for Springer Nature AG & Co. KGaA: cautious scenario $25.29, base $35.97, optimistic $49.91 per share (as of Sep 24, 2026, price $11.44). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of SPGNY?
Springer Nature AG & Co. KGaA trades at a price-to-earnings ratio of 5.5 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $35.97 is built from several models across several years. Other multiples: P/B 1.0, P/S 1.0, EV/EBITDA 4.5.
How solid is the balance sheet of Springer Nature AG & Co. KGaA (SPGNY)?
Balance-sheet figures for Springer Nature AG & Co. KGaA (as of Sep 24, 2026): return on equity 18.5%, debt of 0.70 per unit of equity. They feed the Quality Score of 73/100, which measures business quality independently of the share price.
Which stocks are comparable to Springer Nature AG & Co. KGaA?
From the same area (Communication Services) we also value The New York Times Company, Xinhua Winshare Publishing and Media Co, Jiangsu Phoenix Publishing & Media Corporation, China South Publishing & Media Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Springer Nature AG & Co. KGaA stock attractive at the current price?
The data as of Sep 24, 2026: price $11.44, calculated fair value $35.97 (+214%), Quality Score 73/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SPGNY calculated?
We run Springer Nature AG & Co. KGaA through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $35.97, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Springer Nature AG & Co. KGaA currently trades 68 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Springer Nature AG & Co. KGaA (SPGNY)?
The latest price we hold is from Sep 25, 2026 and stands at $11.44. Our model-based fair value is $35.97, about +214% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Springer Nature AG & Co. KGaA right now?
The rarer combination: high quality (73/100) AND below fair value. That earns a closer look rather than a quick verdict. The price is below even our cautious bear case ($25.29). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($25.29 to $49.91) leaves room in how you read the outcome.

Key figures of Springer Nature AG & Co. KGaA

How large is the market capitalisation of Springer Nature AG & Co. KGaA (SPGNY)?
The market capitalisation of Springer Nature AG & Co. KGaA is $2.3B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Springer Nature AG & Co. KGaA (SPGNY)?
The price-to-sales ratio of Springer Nature AG & Co. KGaA is 1.02 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Springer Nature AG & Co. KGaA (SPGNY)?
Earnings per share at Springer Nature AG & Co. KGaA are $2.07 (price ÷ EPS = P/E 5.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Springer Nature AG & Co. KGaA (SPGNY)?
The dividend yield of Springer Nature AG & Co. KGaA is 7.3% (payout 40.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Springer Nature AG & Co. KGaA (SPGNY)?
The net margin of Springer Nature AG & Co. KGaA is 18.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Springer Nature AG & Co. KGaA (SPGNY)?
The return on equity (ROE) of Springer Nature AG & Co. KGaA is 18.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Springer Nature AG & Co. KGaA (SPGNY)?
On an EBIT basis the return on assets of Springer Nature AG & Co. KGaA is 8.1% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Springer Nature AG & Co. KGaA (SPGNY)?
The operating margin of Springer Nature AG & Co. KGaA is 28.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Springer Nature AG & Co. KGaA (SPGNY)?
Revenue at Springer Nature AG & Co. KGaA is growing +5.5% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Springer Nature AG & Co. KGaA (SPGNY)?
Earnings per share at Springer Nature AG & Co. KGaA are growing +573% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Springer Nature AG & Co. KGaA (SPGNY) carry?
The net debt of Springer Nature AG & Co. KGaA is €1.2B (fiscal year 2025, ≈ 2.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Springer Nature AG & Co. KGaA in the live analysis

One click puts Springer Nature AG & Co. KGaA on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.